PCI术后支架内再狭窄患者血清中谷氨酰转移酶及C反应蛋白与血管新生、炎症反应的相关性

被引:14
作者
卫娇娜 [1 ]
杨睿海 [2 ]
王永进 [1 ]
杜宏艳 [3 ]
机构
[1] 汉中市人民医院心血管内科一病区
[2] 汉中市人民医院心血管研究所
[3] 汉中市人民医院介入室
关键词
经皮冠状动脉介入治疗; 支架内再狭窄; 谷氨酰转移酶; C反应蛋白;
D O I
10.13210/j.cnki.jhmu.20170421.009
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
100201 [内科学];
摘要
目的:研究PCI术后支架内再狭窄患者血清中谷氨酰转移酶(GGT)及C反应蛋白(CRP)与血管新生、炎症反应的相关性。方法:选择2013年4月2016年10月期间在汉中市人民医院心血管内科接受急诊PCI治疗的240例急性冠脉综合征患者,随访PCI术后6个月内支架内再狭窄的发生情况并分为非狭窄组和再狭窄组。PCI术前以及PCI术后第3天、第7天时,采集血清并测定GGT、CRP、血管新生分子、炎性因子的含量。结果:PCI术前及PCI术后第3天、第7天时,再狭窄患者血清中GGT和CRP的含量均显著高于非再狭窄组;PCI术后第7天时,再狭窄患者血清中VEGF、Ang-1、Ang-2的含量显著低于非再狭窄组,IL-6、IL-8的含量均显著高于非再狭窄组;GGT、CRP高含量组患者血清中VEGF、Ang-1、Ang-2的含量显著低于GGT、CRP低含量组,IL-6、IL-8的含量均显著高于GGT、CRP低含量组。结论:术前血清中GGT和CRP含量升高能够加重炎症反应、抑制血管新生,对PCI术后支架内再狭窄具有预测价值。
引用
收藏
页码:1344 / 1347
页数:4
相关论文
共 9 条
[1]
直接经皮冠状动脉介入治疗急性心肌梗死患者血清血管生成素-1和血管生成素-2与心电图ST段回落的相关性 [J].
陈少敏 ;
崔鸣 ;
郭丽君 ;
高炜 .
中国介入心脏病学杂志, 2014, 22 (04) :246-250
[2]
Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality [J].
Simard, Trevor ;
Jung, Richard G. ;
Motazedian, Pouya ;
Di Santo, Pietro ;
Ramirez, F. Daniel ;
Russo, Juan J. ;
Labinaz, Alisha ;
Yousef, Altayyeb ;
Anantharam, Brijesh ;
Pourdjabbar, Ali ;
Hibbert, Benjamin .
STEM CELLS INTERNATIONAL, 2017, 2017
[3]
Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease.[J].Gjin Ndrepepa;Erion Xhepa;Roisin Colleran;Siegmund Braun;Salvatore Cassese;Massimiliano Fusaro;Karl-Ludwig Laugwitz;Adnan Kastrati.Clinica Chimica Acta.2017,
[4]
Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI [J].
Gungor, Baris ;
Karatas, Mehmet Baran ;
Ipek, Gokturk ;
Ozcan, Kazim Serhan ;
Canga, Yigit ;
Onuk, Tolga ;
Keskin, Muhammed ;
Hayiroglu, Mert Ilker ;
Karadeniz, Fatma Ozpamuk ;
Sungur, Aylin ;
Ozturk, Recep ;
Bolca, Osman .
RENAL FAILURE, 2016, 38 (08) :1167-1173
[5]
Association of γ-glutamyl transferase with premature coronary arterydisease.[J].Madankumar Ghatge;Ankit Sharma;Rajani Vangala.Biomedical Reports.2016, 3
[6]
Endothelial Progenitor Cells and In-stent Restenosis [J].
Xu, Bu-Yun ;
Xiang, Mei-Xiang ;
Wang, Jian-an .
CURRENT STEM CELL RESEARCH & THERAPY, 2015, 10 (04) :364-371
[7]
Interleukins and Inflammatory Markers in In-Stent Restenosis after Femoral Percutaneous Transluminal Angioplasty [J].
Araujo, Paula Vasconcelos ;
Ribeiro, Mauricio Serra ;
Dalio, Marcelo Bellini ;
Rocha, Laura Andrade ;
Viaro, Fernanda ;
Joviliano, Renata Dellalibera ;
Piccinato, Carlos Eli ;
Barbosa Evora, Paulo Roberto ;
Joviliano, Edwaldo Edner .
ANNALS OF VASCULAR SURGERY, 2015, 29 (04) :731-737
[8]
Role of Pre-procedural C-reactive Protein Level in the Prediction of Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention: a Meta-analysisof Longitudinal Studies [J].
Bibek, Singh-baniya ;
Xie, Yong ;
Gao, Jia-jia ;
Wang, Zhi ;
Wang, Jing-feng ;
Geng, Deng-feng .
INFLAMMATION, 2015, 38 (01) :159-169
[9]
The late-phase inflammatory response after drug-eluting stent implantation [J].
Taguchi, Isao ;
Yoneda, Shuichi ;
Abe, Shichiro ;
Toyoda, Shigeru ;
Nasuno, Takahisa ;
Nishino, Setsu ;
Kageyama, Michiya ;
Tokura, Michiaki ;
Ogawa, Mikie ;
Node, Koichi ;
Inoue, Teruo .
HEART AND VESSELS, 2014, 29 (02) :213-219